(Q45749202)

15 December 2017

title

Exacerbation of glomerulonephritis in subjects with chronic hepatitis C virus infection after interferon therapy (English)

1 reference

15 December 2017

1 reference

1 reference

1 reference

Ohta S

1

1 reference

15 December 2017

Yokoyama H

2

1 reference

15 December 2017

Wada T

3

1 reference

15 December 2017

Sakai N

4

1 reference

15 December 2017

Shimizu M

5

1 reference

15 December 2017

Kato T

6

1 reference

15 December 2017

Furuichi K

7

1 reference

15 December 2017

Segawa C

8

1 reference

15 December 2017

Hisada Y

9

1 reference

15 December 2017

Kobayashi K

10

1 reference

15 December 2017

publication date

1 June 1999

1 reference

15 December 2017

American Journal of Kidney Diseases

published in

1 reference

15 December 2017

volume

33

1 reference

15 December 2017

issue

6

1 reference

15 December 2017

page(s)

1040-1048

1 reference

15 December 2017

Membranoproliferative glomerulonephritis associated with hepatitis C virus infection

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970140-X

7 January 2021

Hepatitis C virus-associated glomerulonephritis. Effect of alpha-interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970140-X

7 January 2021

Progressive glomerulonephritis in mice treated with interferon preparations at birth

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970140-X

7 January 2021

Minimal-change glomerulopathy and glomerular visceral epithelial hyperplasia associated with alpha-interferon therapy for cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970140-X

7 January 2021

Acute interstitial nephritis with the nephrotic syndrome following recombinant leukocyte a interferon therapy for mycosis fungoides

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970140-X

7 January 2021

Unusual glomerular lesion in a patient receiving long-term interferon alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970140-X

7 January 2021

Membranoproliferative glomerulonephritis in a patient with hairy-cell leukemia treated with alpha-II interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970140-X

7 January 2021

Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970140-X

7 January 2021

A structural protein of hepatitis C virus expressed in E. coli facilitates accurate detection of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970140-X

7 January 2021

Clinicopathological analysis and therapy in hepatitis C virus-associated nephropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970140-X

7 January 2021

Clinical toxicity of interferons in cancer patients: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970140-X

7 January 2021

Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970140-X

7 January 2021

Tagging T cells: TH1 or TH2?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970140-X

7 January 2021

Induction of TH1 and TH2 responses: a key role for the 'natural' immune response?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970140-X

7 January 2021

The neglected role of type I interferon in the T-cell response: implications for its clinical use

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970140-X

7 January 2021

Th1 responsiveness to nephritogenic antigens determines susceptibility to crescentic glomerulonephritis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970140-X

7 January 2021

Up-regulated MHC-class II expression and gamma-IFN and soluble IL-2R in lupus nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970140-X

7 January 2021

Intraglomerular expression of MHC class II and Ki-67 antigens and serum gamma-interferon levels in IgA nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970140-X

7 January 2021

Glomerular ICAM-1 expression related to circulating TNF-alpha in human glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970140-X

7 January 2021

Membranoproliferative glomerulonephritis in a patient treated with interferon-alpha for human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970140-X

7 January 2021

Immunoregulatory effects of interferon-beta and interacting cytokines on human vascular endothelial cells. Implications for multiple sclerosis autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970140-X

7 January 2021

Modulation of expression of MHC antigens in the kidneys of mice by murine interferon-alpha/beta

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2899%2970140-X

7 January 2021

10.1016/S0272-6386(99)70140-X

Identifiers

DOI

1 reference

15 December 2017

1 reference

15 December 2017